The global hyperlipidemia drugs market is witnessing steady growth as healthcare systems place greater emphasis on cardiovascular disease prevention, early diagnosis, and long-term lipid management. According to recent market analysis, the global hyperlipidemia drugs market was valued at USD 24.42 billion in 2025 and is projected to grow from USD 25.05 billion in 2026 to USD 30.76 billion by...
Anti-Obesity Prescription Drugs Market to Reach USD 4.35 Billion by 2032, Driven by Rising Global Obesity Rates
The Anti-Obesity Prescription Drugs Market was valued at USD 2.97 billion in 2024 and is projected to reach USD 4.35 billion by 2032, expanding at a CAGR of 4.9% during 2025–2032. The market is witnessing steady growth due to the alarming rise in...
Chronic lower back pain (CLBP) is one of the most common health issues worldwide, affecting millions of people, particularly those leading a sedentary lifestyle. The global chronic lower back pain treatment market was valued at USD 8.29 billion in 2024 and is expected to grow at a CAGR of 4.9% during the forecast period from 2025 to 2034. By 2034, the market is projected to reach USD 12.75...
